Sarepta Therapeutics Inc (SRPT)
118.97
-0.50
(-0.42%)
USD |
NASDAQ |
Dec 20, 16:00
119.11
+0.14
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics Profit Margin (Quarterly): 7.19% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals Inc | -- |
| Eli Lilly and Co | 8.48% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Catalyst Pharmaceuticals Inc | 34.10% |
| Vertex Pharmaceuticals Inc | 37.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.48% |
| Return on Assets | 3.66% |
| Return on Invested Capital | 5.51% |
| Gross Profit Margin (Quarterly) | 80.37% |
| Operating Margin (Quarterly) | 4.75% |
| Return on Net Operating Assets | 8.26% |